Stay updated on PemCab in Cisplatin-Ineligible UC Clinical Trial

Sign up to get notified when there's something new on the PemCab in Cisplatin-Ineligible UC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PemCab in Cisplatin-Ineligible UC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the completed PemCab study of cabozantinib plus pembrolizumab for advanced urothelial carcinoma, with its study details, participant criteria, outcome measures, and supporting documents.
    Difference
    55%
    Check dated 2026-11-07T12:22:56.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:05:56.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:21:55.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer now shows site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T17:07:16.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:00:28.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the detailed study content with a minimal error screen. Previously visible items such as study details, locations, and contacts are not shown in this view.
    Difference
    20%
    Check dated 2026-09-19T21:47:23.000Z thumbnail image

Stay in the know with updates to PemCab in Cisplatin-Ineligible UC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PemCab in Cisplatin-Ineligible UC Clinical Trial page.